Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Juneja

Showing results (181-190 of 195) with videos related to

Pageof 20
Sort By:
The Journal of Experimental Medicine|September 16, 2015
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunityAlison M Paterson, Scott B Lovitch, Peter T Sage, et al.
Cancer Immunology Research|October 12, 2021
Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune ResponsesXia Bu, Vikram R Juneja, Carol G Reynolds, et al.
Cancer Immunology Research|December 5, 2020
Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8<sup>+</sup> T CellsJefte M Drijvers, Jacob E Gillis, Tara Muijlwijk, et al.
Cancer Immunology Research|June 7, 2014
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockadeZachary A Cooper, Vikram R Juneja, Peter T Sage, et al.
Cell Reports Methods|April 27, 2022
Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutationsJaewon Choi, Scott P Goulding, Brandon P Conn, et al.
The Journal of Experimental Medicine|October 12, 2020
PD-1 restraint of regulatory T cell suppressive activity is critical for immune toleranceCatherine L Tan, Juhi R Kuchroo, Peter T Sage, et al.
The Journal of Experimental Medicine|July 24, 2025
PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashionKristen E Pauken, Samuel C Markson, Thomas S Conway, et al.
Cell|September 12, 2015
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor GrowthSonja Kleffel, Christian Posch, Steven R Barthel, et al.
Nature|July 21, 2017
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy targetRobert T Manguso, Hans W Pope, Margaret D Zimmer, et al.
Nature Communications|November 24, 2025
Incommensurate Transverse Peierls Transition and Signature of Chiral Charge Density Wave in EuAl<sub>4</sub>F Z Yang, K F Luo, Weizhe Zhang, et al.
Pageof 20

Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
The Journal of Experimental Medicine|September 16, 2015
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunityAlison M Paterson, Scott B Lovitch, Peter T Sage, et al.
Cancer Immunology Research|October 12, 2021
Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune ResponsesXia Bu, Vikram R Juneja, Carol G Reynolds, et al.
Cancer Immunology Research|December 5, 2020
Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8<sup>+</sup> T CellsJefte M Drijvers, Jacob E Gillis, Tara Muijlwijk, et al.
Cancer Immunology Research|June 7, 2014
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockadeZachary A Cooper, Vikram R Juneja, Peter T Sage, et al.
Cell Reports Methods|April 27, 2022
Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutationsJaewon Choi, Scott P Goulding, Brandon P Conn, et al.
The Journal of Experimental Medicine|October 12, 2020
PD-1 restraint of regulatory T cell suppressive activity is critical for immune toleranceCatherine L Tan, Juhi R Kuchroo, Peter T Sage, et al.
The Journal of Experimental Medicine|July 24, 2025
PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashionKristen E Pauken, Samuel C Markson, Thomas S Conway, et al.
Cell|September 12, 2015
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor GrowthSonja Kleffel, Christian Posch, Steven R Barthel, et al.
Nature|July 21, 2017
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy targetRobert T Manguso, Hans W Pope, Margaret D Zimmer, et al.
Nature Communications|November 24, 2025
Incommensurate Transverse Peierls Transition and Signature of Chiral Charge Density Wave in EuAl<sub>4</sub>F Z Yang, K F Luo, Weizhe Zhang, et al.
Pageof 20